News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
QIAGEN N.V. Expects to Make Biggest Acquisition Since $1.6 Billion Digene Corporation Buy
March 15, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Qiagen NV (QIA), the Dutch company whose tools are used to predict disease and isolate DNA, may make its second-biggest acquisition to date this year.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
MORE ON THIS TOPIC
Mergers & acquisitions
BioMarin Expands Enzyme Expertise With $270M Inozyme Buy
May 16, 2025
·
2 min read
·
Tristan Manalac
RNA editing
Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss Pipeline
May 16, 2025
·
2 min read
·
Tristan Manalac
Deals
Bluebird’s Private Equity Buyout Boosts Upfront Cash for Shareholders
May 15, 2025
·
1 min read
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
·
2 min read
·
Dan Samorodnitsky
